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S U M M A R Y
Objectives: To report three cases of emphysematous prostatic abscess (EPA) and review the literature on
this rare entity.
Methods: All relevant articles published in English over the last 50 years (1961–2011) were identiﬁed
using a MEDLINE search for keywords ‘emphysematous prostatitis’ and ‘emphysematous prostatic
abscess’. A total of 12 patients were evaluated for their age, race, underlying disease, pathogens,
diagnosis tool, treatment options, and clinical outcome.
Results: EPA is a high mortality disease (25%) and has an association with diabetes mellitus. The most
common pathogen in the 12 cases was Klebsiella pneumoniae.
Conclusions: The mortality of EPA is higher than that of emphysematous cystitis and emphysematous
pyelonephritis. Timely recognition and prompt drainage are very important.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Gas-forming urinary tract infections (UTIs), ﬁrst described in
1671, are rare and have a high mortality rate (70–90%).1 The
reported predisposing factors for these gas-forming UTIs include
an immunosuppressed status, diabetes mellitus (DM), liver
cirrhosis, alcoholism, and recent urethral instrumentation, while
the reported etiologic pathogens in these infections include
Escherichia coli, Klebsiella pneumoniae,2 Proteus mirabilis, Citrobac-
ter, and yeasts.3 Among them, emphysematous prostatic abscess
(EPA), which is characterized by gas and purulent exudate
formation in the prostate gland, is less reported in the literature;
the ﬁrst case of EPA was reported in 1983.4
Emphysematous infections are typically deﬁned and diagnosed
by radiological imaging. Due to advances in abdominal–pelvic
imaging and a greater awareness of such infections, the incidence
of reported cases has increased. However, the number of these
emphysematous UTIs might still be under-reported and under-
diagnosed because imaging modalities are not routinely used in
the diagnosis of UTIs.* Corresponding author. Tel.: +886 7 3121101 ext. 6694; fax: +886 7 3121033.
E-mail address: Carl0815@gmail.com (M.-Y. Jang).
1 The ﬁrst two authors contributed to this article equally.
1201-9712/$36.00 – see front matter  2012 International Society for Infectious Disea
doi:10.1016/j.ijid.2012.01.002We report herein three cases of EPA and the ﬁndings of a
structured comprehensive literature review.
2. Case reports
2.1. Case one
A 72-year-old male presented with fever, dysuria, urinary
frequency, and anal pain, and was admitted to our hospital; he
denied having DM and alcoholism. Acute urine retention was
noted 1 day prior to this admission, and he had undergone a
transurethral Foley catheterization at a local hospital for a
presumed prostatic obstruction. However, fever with chills and
rectal tenesmus occurred hours later and he attended our hospital.
On physical examination, the patient was febrile (body tempera-
ture 39 8C) and had a normal blood pressure; the prostate was
uniformly enlarged, soft without ﬂuctuance, and moderately
tender during a digital rectal examination.
Laboratory data on admission revealed leukocytosis and
elevated C-reactive protein (CRP); other laboratory data are
summarized in Table 1. Abdominal radiography (Figure 1A)
showed a collection of air pockets in the lower pelvic cavity in
the area of the prostate. Intravenous levoﬂoxacin was adminis-
tered for a presumed acute prostatitis. Because the fever persistedses. Published by Elsevier Ltd. All rights reserved.
Table 1
Laboratory data upon admission
Case 1 Case 2 Case 3
Urinalysis (normal range)
Protein (Neg) Neg Neg 2+
RBC (0–2/HPF) 10–25 2–5 10–25
WBC (0–2/HPF) 0–2 10–25 >100
CBC (normal range)
WBC (4.4–11.3  109/l) 13.03 12.08 16.94
Hb (12.3–17.5 mg/dl) 12.7 11.1 12
Platelets (172–450  109/l) 15 53 21.5
Serological test (normal range)
CRP (<5 mg/l) 109.7 43.1 236.2
Blood chemistry (normal range)
AST (10–42 IU/l) 45 101 72
ALT (10–42 IU/l) 26 111 31
BUN (8–20 mg/dl) 13 17.2 23
Creatinine (0.6–1.4 mg/dl) 1.04 0.93 2.63
Sodium (136–144 mEq/l) 136 133 137
Potassium (3.5–5.1 mEq/l) 3.8 3.9 3.6
Chloride (99–109 mEq/l) 100 108 103
Glucose (65–109 mg/dl) 105 120 126
PT/control PT (s) 11.7/10.8 15.6/11.0 10.6/10.9
aPTT/control aPTT (s) 28.4/28.5 58.9/29.0 31.3/29.3
PSA (0–4 ng/ml) 0.937 0.877 2.19
ALT, alanine aminotransferase; aPTT, activated partial thromboplastin time; AST,
aspartate aminotransferase; BUN, blood urea nitrogen; CBC, complete blood count;
CRP, C-reactive protein; Hb, hemoglobin; HPF, high-power ﬁeld; PSA, prostate-
speciﬁc antigen; PT, prothrombin time; RBC, red blood cell; WBC, white blood cell.
Figure 1. (A) Air collections (arrow) appeared around the pubic symphysis in a scout KU
interposed acoustic air shadows (arrow). (C) Contrast-enhanced pelvic CT demonstrate
Indwelling prostatic abscess drainage (7-F pigtail catheter), under CT guide via transgl
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scanning of the prostate was performed; diffuse hypoechoic
changes with acoustic shadows were seen (Figure 1B). Prostate
abscess without lobulation was considered and a transrectal
aspiration was attempted but failed due to the presence of
acoustic shadow. Abdominal computed tomography (CT) showed
swelling of the prostate with air and ﬂuid accumulation,
suggestive of EPA (Figure 1C). A 7-F pigtail drainage tube was
deployed along the left gluteus muscle under a CT-guided
transgluteal approach (Figure 1D). Twenty milliliters of greenish
pus were drained initially, with a subsequent daily drainage
amount of 15–20 ml. A suprapubic trocar cystostomy was
performed for urinary diversion and the transurethral Foley
catheter was removed. The patient’s general condition and vital
signs improved dramatically after insertion of the drainage tube.
Cultures of blood and urine taken on admission and pus cultures
grew K. pneumoniae with the same antibiogram, which was
resistant to ampicillin and trimethoprim/sulfamethoxazole. On
day 15, the drainage tube was removed and the patient discharged
home with the cystostomy in place. Oral levoﬂoxacin 750 mg/day
was prescribed for another 4 weeks. TRUS of the prostate 1 month
later showed complete resolution of the EPA. The cystostomy tube
was removed 6 weeks later. He received regular follow-up for
another 4 months and remained free of any lower urinary tract
symptoms.B ﬁlm. (B) Transrectal ultrasonography: diffuse hypoechogenicity of prostate with
d extensive swelling of the prostate with air and ﬂuid accumulation (arrow). (D)
uteal access.
Figure 3. Non-enhanced coronal abdominal CT revealed emphysematous prostatic
abscess, perivesical gas accumulation (arrow), and associated left hydronephrosis
(arrow head).
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A 68-year-old man was brought to our emergency department
with complaints of dysuria, a burning sensation during urination,
and fever lasting for 2 days. He had a 5-year history of type II DM
without regular control. He also had hepatitis C, Child class B liver
cirrhosis, and hepatic encephalopathy.
On arrival the patient was slightly hypotensive (blood pressure
98/58 mmHg) and tachycardic (heart rate 132 bpm). He was febrile
(39.2 8C) and his respiratory rate was 56 per min. A soft, non-
tender prostate was palpated during digital rectal examination.
Laboratory data upon admission are summarized in Table 1. Yeast-
like material and Gram-negative bacilli were identiﬁed in the urine
initially. Because the tentative clinical diagnosis was UTI with
septic shock, initial management consisted of Foley catheteriza-
tion, ﬂuid challenge, strict control of blood sugar, and intravenous
administration of amoxicillin/clavulanate and ﬂuconazole. Later
on, Candida albicans grew on pus and urine cultures. Abdominal
ultrasonography performed on day 3 showed liver cirrhosis,
bilateral renal cysts, and right hydronephrosis. Because the fever
persisted despite the administration of antibiotics, an abdominal
CT was arranged on day 7 and showed intramural gas formation in
the prostate gland (Figure 2), suggesting EPA. A suprapubic trocar
cystostomy was contraindicated because of coagulopathy. CT-
guided transperineal abscess drainage was performed. A 7-F pigtail
catheter was inserted and 10 ml of chocolate-like pus mixed with
gas were drained initially, with daily drainage of 10–15 ml
thereafter. The pigtail catheter was removed on day 11 because
shrinkage of the abscess was identiﬁed on pelvic CT.
The patient was discharged 2 weeks later with a Foley catheter
in place. Oral antibiotics (levoﬂoxacin and ﬂuconazole) were
prescribed for another 5 weeks, until the pyuria resolved. The Foley
catheter was removed 2 weeks later in the outpatient clinic.
2.3. Case three
An 81-year-old non-diabetic male patient was admitted to our
hospital because of abdominal pain, poor appetite, and little
defecation for 1 week. He had undergone a transurethral radio-
frequency needle ablation (TUNA) for an enlarged prostate 2 weeks
earlier. On admission, his level of consciousness was altered; he
was drowsy and hypotensive. Laboratory data revealed leukocy-
tosis and an abnormal CRP. Laboratory data upon admission are
summarized in Table 1.
The transurethral Foley catheter had been kept in place after the
TUNA procedure. Abdominal X-ray revealed prominent bowel gas,Figure 2. Pelvic CT revealed a gas collection (arrow) in the prostate gland.and ileus was suspected. Abdominal ultrasonography revealed left
hydronephrosis, while CT of the abdomen showed not only left
hydronephrosis, but also gas and pus collection extending from the
prostate to the perivesical region (Figure 3). Fluid resuscitation and
antibiotic treatment (levoﬂoxacin initially, then changed to
meropenem + ﬂuconazole in accordance with the culture reports)
were administered. The urethral Foley catheter was removed and a
left percutaneous nephrostomy was performed on the day of
admission. CT-guided pigtail drainage of the abscess was carried out
and dark green pus was drained. Extended-spectrum beta-
lactamase (ESBL)-producing E. coli and Candida glabrata grew on
the cultures of urine and pus. Because the creatinine level of the
drained ﬂuid was compatible with that in urine, a prostatic ﬁstula
was suspected. Urethrography revealed leakage of contrast at the
prostatic urethra, which was compatible with prostatic ﬁstula. With
the development of the prostatic ﬁstula, the amount of drainage
declined day by day and the drainage tube was removed on
hospitalization day 35. The patient was discharged home on day 45.
3. Methods
We searched the MEDLINE database and The Cochrane Library
Central Search database for English language publications over the
last 50 years (1961–2011) using the search terms ‘emphysematous
prostatitis’ and ‘emphysematous prostatic abscess’. Reports on
nine patients with EPA were identiﬁed. These nine patients and the
three patients from the present case reports (n = 12) were
evaluated for their age, race, underlying diseases, urinary
pathogens, imaging methods, treatment options, and clinical
outcomes.
4. Results
Twelve male patients were included in this study. Clinical data
are summarized in Table 2. The mean  standard deviation age of
the patients at presentation was 60.3  9.2 years. DM was associated
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Table 3
Summary of the 12 cases of emphysematous prostate abscess
Variable Value
Age (years), mean  SD 60.3  9.2
Immunocompromised status, n (%) 10 (83.3)
DM 10 (83.3)
Liver cirrhosis 3 (25)
Alcoholism 2 (16.7)
ESRD 1 (8.3)
Other (transplant under immunosuppressant) 1 (8.3)
Hospital stay (days), mean 32.5
Overall death rate 25%
Pathogen (12 cases), n (%)
Klebsiella pneumoniae 6 (50)
Candida 3 (25)
Escherichia coli 2 (16.7)
Pseudomonas aeruginosa 1 (8.3)
Bacteroides fragilis 1 (8.3)
Mixed 2 (16.7)
S.-C. Wen et al. / International Journal of Infectious Diseases 16 (2012) e344–e349 e347with EPA in 10 of the 12 cases (83.3%). All three patients who died
from EPA had DM. Various bacterial and fungal organisms were
isolated in urinary and/or pus cultures, with K. pneumoniae being the
most prevalent pathogen (6/12 cases; 50%). Other organisms reported
included Candida species, E. coli, Pseudomonas aeruginosa, and
Bacteroides fragilis. Two cases had mixed infections (Table 3).
The diagnoses of all cases were conﬁrmed by abdominal CT and/
or TRUS. The treatments of most cases included intravenous
antibiotics, suprapubic cystostomy, and pus drainage/aspiration.
Half of the cases (6/12) were drained by transurethral incision or
abscess unrooﬁng. A third were successfully drained by percuta-
neous CT-guided drainage (perineal approach or transgluteal
approach). The hospital stay was recorded in six cases, including
the three present cases, and the average length of hospital stay was
32.5 days. The mortality rate was 25% (3/12); interestingly,
prostate-speciﬁc antigen levels were within the normal range (<4
ng/ml) in these three cases.
5. Discussion
Prostate abscess is an uncommon but potentially serious
disorder. The mortality rate was up to 30% in the pre-antibiotic era,
with the most common causative pathogen being Neisseria
gonorrhoeae. The current reported mortality rate is 3–18%,5,6 with
enterobacteria being the most common pathogens. According to
the present review, the mortality of EPA is higher, at 25%. Most
prostate abscess patients have presented in their ﬁfth and/or sixth
decade, which is similar to the EPA patients.7–11
Based on previous reports, patients with DM are prone to have
complicated UTIs such as EPA, emphysematous cystitis, or renal
abscess. Other predisposing factors include urinary retention (e.g.,
bladder outlet obstruction, neurogenic bladder), urethral instru-
mentation (e.g., indwelling urethral catheters, TUNA, transurethral
microwave thermotherapy (TUMT)), underlying systemic diseases
(e.g., DM, liver cirrhosis, post-renal transplant status12), and
recurrent UTIs. However, as shown in our cases, patients with well-
controlled DM or without DM may also develop emphysematous
UTIs.13
As for prostate abscesses, no pathognomonic symptoms or signs
are speciﬁc for EPA. The major presentations of EPA have been UTIs
with symptoms of dysuria, frequency, and urgency. Common
complaints at initial presentation have included fever, acute urine
retention, perineal pain, tenesmus, and lower abdominal discom-
fort. It is very hard to tell EPA from acute prostatitis or prostate
abscess by symptoms and signs alone. Digital rectal examination
has usually revealed local tenderness, increased prostate size, and
a soft and ﬂuctuant prostate.
S.-C. Wen et al. / International Journal of Infectious Diseases 16 (2012) e344–e349e348A plain ﬁlm of kidney, ureter and bladder (KUB) was done in
every documented report, but it was difﬁcult to conﬁrm the
diagnosis by KUB alone for the adjacent bowel gaseous shadows,
and it was difﬁcult to differentiate EPA from emphysematous
cystitis. Intravenous pyelography for EPA has also been reported,4
but the nonspeciﬁc image ﬁndings, such as elevated bladder base,
irregularities of prostatic lobes, and mild to moderate urethral
dilatation, can occur in any prostatic pathology.14 Cystoscopy is of
little use in the diagnosis of EPA.15 Although prostate abscess can
be diagnosed by TRUS,16 emphysematous infection would be hard
to detect for the interference of air. Both prostatic calciﬁcation and
air pockets in the prostate are hyperechoic with acoustic shadows
on sonography. A CT scan was able to demonstrate an enlarged
prostate with low-attenuated abscess and gas accumulation,17 and
is considered the best diagnostic modality for EPA so far.
EPA, like emphysematous pyelonephritis, appears to be
geographically more common in Asia. Different from other gas-
forming UTIs, K. pneumoniae (50%) rather than E. coli (16.7%)
appears to be the most common causative pathogen of EPA.
Geographic differences in K. pneumoniae have been recognized. A
prior study conducted in Taiwan documented a high prevalence of
capsular K1/K2 serotypes of capsular polysaccharide (CPS) in liver
abscesses resulting from K. pneumoniae infection.18 Lin et al.
demonstrated that CPS serotype K1/K2 isolates are signiﬁcantly
more resistant to phagocytosis than non-K1/K2 isolates.19 A recent
study demonstrated serotype K1 K. pneumoniae with multi-locus
sequence type ST23 to be strongly associated with liver abscess in
the Asian region.20 Outside Asia, K. pneumoniae liver abscess has
been reported more frequently in patients of Asian descent than
non-Asians.21,22 Whether such geographic and serotypic differ-
ences in K. pneumoniae play a role in EPA or emphysematous
pyelonephritis in Asian populations needs further investigation.
Other reported pathogens for EPA include B. fragilis, Candida
species,23 and P. aeruginosa. Candida species were more prevalent
in EPA (25% in these cases) than in other UTIs. However, due to the
small number of reported cases, further study is warranted.
The deﬁnite treatment option of EPA is surgical drainage.
Abscess drainage may be performed by transurethral resection of
the prostate (TURP), open perineal incision, or TRUS-guided
transperineal needle aspiration.24 The transurethral approach
should be done in selected patients who are hemodynamically
stable and able to tolerate the anesthesia. At the acute infectious
stage, this should be done very carefully because hydrostatic
pressure during the transurethral procedure may push pathogens
from the urothelium into the systemic blood stream and lead to
sepsis or septic shock. Only when primary aspiration is done and
the patient is stable should TURP be arranged to remove the
residual abscess.
Transrectal aspiration of a prostatic abscess could be performed
under TRUS guidance and local anesthesia. However this proce-
dure may be hard to perform precisely for EPA patients because
ultrasound waves are reﬂected by gas and there is interference of
acoustic shadow from prostate calciﬁcation and air collections, as
occurred in our case one. Open perineal incision has been reported,
although the patient eventually died.25 CT-guided transcutaneous
(transperineal or transgluteal) abscess drainage for EPA is
suggested, because the abscess can be drained more precisely
and more thoroughly than US-guided drainage or aspiration.
As a rule of thumb, in patients with acute urine retention
secondary to acute prostatitis or prostatic abscess, urine ﬂow
should be diverted with a suprapubic cystostomy tube because
urethral instrumentation may aggravate sepsis. However, in some
cases when cystostomy is contraindicated, a urethral catheter
could be carefully used instead. At present, there is no consensus
on the duration of cystostomy insertion. Once a cystostomy is
performed, the reported duration of placement is variable (6 weeksto 3 months). Antibiotic treatments with a third-generation
cephalosporin or quinolone alone, or in combination with
metronidazole or gentamicin, have been reported. Prolonged
administration of antibiotics for 4–6 weeks is essential to
completely eradicate the pathogens.
Recently, mini-invasive surgeries have been introduced for the
treatment of benign prostate hyperplasia. These procedures
include TUNA, TUMT, and photoselective vaporization. EPA has
been reported as a rare complication of TUMT,25 and we have
reported the ﬁrst case of EPA after TUNA. The mechanism of TUNA
is the transmission of low level radiofrequency energy to the
prostate via a transurethral needle delivery system. The resultant
heat causes localized necrosis of the prostate. The advantages of
TUNA include local anesthesia with or without intravenous
sedation, its low cost, and no reported adverse effects on sexual
function. The histopathology of prostatic tissue after transurethral
hyperthermia has been shown to consist of periurethral edema,
parenchymal hemorrhage, and coagulation necrosis of the smooth
muscle as acute changes, and interstitial hemorrhages, complete
obliteration of blood vessel lumina, and hemorrhagic necrosis as
late changes.26 The most common complications after TUNA
include bleeding (33%), UTI (10%), and urethral stricture (2%). EPA
may be a delayed result of coagulation necrosis and hemorrhages
of the prostate parenchyma combined with UTI.25
In conclusion, EPA is a highly morbid gas-forming infection of
the urinary tract. The mortality rate of EPA (25%) is higher than that
of emphysematous cystitis (7%)27 and emphysematous pyelone-
phritis (21%).7,28 In patients with DM and other associated risk
factors, we should maintain a high degree of suspicion when they
do not respond well to medical management. Once EPA is
suspected, CT should be performed, not only for diagnosis but
also for prompt abscess drainage.29 Early detection, prompt
drainage, and sufﬁcient antibiotic treatment are crucial to avoid
the potential morbidity and mortality associated with this serious
infection.
Conﬂict of interest: No conﬂict of interest to declare.
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